当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:253.94亿  总市值:385.25亿
流通股本:5.70亿   总股本:8.65亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,630,273,549.066,785,119,210.174,856,126,172.223,056,322,442.94
收到的税费返还308,078.91615,206.982,149,719.161,183,047.88
收到其他与经营活动有关的现金21,898,964.34175,028,505.84135,443,635.26109,908,791.08
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,652,480,592.316,960,762,922.994,993,719,526.643,167,414,281.9
购买商品、接受劳务支付的现金473,163,748.751,960,341,102.441,378,495,566.27848,583,328.12
支付给职工以及为职工支付的现金772,187,943.293,123,669,809.042,298,577,074.561,609,200,179.32
支付的各项税费96,528,524.28524,720,429.49436,973,562.51323,762,293.83
支付其他与经营活动有关的现金112,665,761.81255,029,678.28300,903,713.35208,540,095.92
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,454,545,978.135,863,761,019.254,414,949,916.692,990,085,897.19
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额197,934,614.181,097,001,903.74578,769,609.95177,328,384.71
二、投资活动产生的现金流量:
收回投资收到的现金117,616,398.622,088,507,799.04619,025,446.77286,899,076.47
取得投资收益收到的现金31,280,078.1362,540,443.5833,510,950.6913,078,605.87
处置固定资产、无形资产和其他长期资产收回的现金净额34,718.32,335,687.89188,383.44128,657.76
收到的其他与投资活动有关的现金1,158.7917,676,031.214,687,103.1513,835,699.65
投资活动现金流入的平衡项目0000
投资活动现金流入小计148,932,353.842,171,059,961.71667,411,884.05313,942,039.75
购建固定资产、无形资产和其他长期资产支付的现金48,094,554.92356,554,496.96278,061,741.81202,262,777.11
投资支付的现金747,793,521.76,176,067,436.976,091,185,860.34,733,489,965.34
取得子公司及其他营业单位支付的现金2,258,635.58367,354,142.1920,964,321.47-
支付其他与投资活动有关的现金8,654,88010,206,300316,860-
投资活动现金流出的平衡项目0000
投资活动现金流出小计806,801,592.26,910,182,376.126,390,528,783.584,935,752,742.45
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-657,869,238.36-4,739,122,414.41-5,723,116,899.53-4,621,810,702.7
三、筹资活动产生的现金流量:
吸收投资收到的现金62,600,00078,560,00061,900,00031,300,000
其中:子公司吸收少数股东投资收到的现金---31,300,000
取得借款收到的现金555,356,0003,379,458,927.12,843,516,597.921,515,318,400
收到其他与筹资活动有关的现金-128,097,800.76107,255,379.2954,500,229.06
筹资活动现金流入平衡项目0000
筹资活动现金流入小计617,956,0003,586,116,727.863,012,671,977.211,601,118,629.06
偿还债务支付的现金319,007,7483,880,222,821.922,035,406,823.68742,705,523.51
分配股利、利润或偿付利息支付的现金27,059,863.38642,156,083.35608,854,337.0383,954,901.98
其中:子公司支付给少数股东的股利、利润---19,797,431.75
支付其他与筹资活动有关的现金375,754,195.12766,148,050.22640,412,502.45568,248,193.06
筹资活动现金流出平衡项目0000
筹资活动现金流出小计721,821,806.55,288,526,955.493,284,673,663.161,394,908,618.55
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-103,865,806.5-1,702,410,227.63-272,001,685.95206,210,010.51
四、汇率变动对现金及现金等价物的影响4,959,416.33-6,916,778.71-21,705,538.241,473,866.18
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-558,841,014.35-5,351,447,517.01-5,438,054,513.77-4,236,798,441.3
加:期初现金及现金等价物余额2,048,493,852.847,399,941,369.857,399,941,369.857,399,941,369.85
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,489,652,838.492,048,493,852.841,961,886,856.083,163,142,928.55
补充资料:
净利润-447,831,286.97-557,578,693.92
资产减值准备-34,020,755.81-36,083,691.56
固定资产和投资性房地产折旧-116,428,764.15-56,349,034.77
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-116,428,764.15-56,349,034.77
无形资产摊销-88,792,330.09-44,831,032.73
长期待摊费用摊销-39,895,400.15-19,900,452.34
处置固定资产、无形资产和其他长期资产的损失--3,563,278.83--1,489,722.71
公允价值变动损失-501,688,166.32-98,403,141.06
财务费用-123,213,890.6-52,808,964.67
投资损失--166,642,230.65--70,743,456.58
递延所得税--6,757,746.83-6,199,820.03
其中:递延所得税资产减少-11,612,941.68-11,465,967.19
递延所得税负债增加--18,370,688.51--5,266,147.16
存货的减少-3,658,293.2-1,260,726.4
经营性应收项目的减少--1,016,962,949.53--585,332,527.34
经营性应付项目的增加-751,590,196.71--145,795,782.17
其他-64,889,880.19-47,982,352.97
现金的期末余额-2,048,493,852.84-3,163,142,928.55
减:现金的期初余额-7,399,941,369.85-7,399,941,369.85
公告日期2025-04-292025-03-282024-10-302024-08-29
审计意见(境内)标准无保留意见
TOP↑